查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1584646

醫院和護理機構益生菌的全球市場：按產品、按應用、按地區、趨勢分析、競爭格局、預測，2019-2030

Hospital and Nursing Home Probiotics Market, By Product; By Application; By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa ), Global Trend Analysis, Competitive Landscape & Forecast, 2019-2030
出版日期: | 出版商: Blueweave Consulting | 英文 510 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

到 2030 年，全球醫院和療養院益生菌市場將超過 9,100 萬美元

由於人們對腸道健康的認知不斷提高、擴大使用益生菌來預防感染疾病、人口不斷成長以及對個人化醫療的需求不斷成長，全球醫院和療養院的益生菌市場正在蓬勃發展。

領先的策略諮詢和市場研究公司 BlueWeave Consulting 在最新研究中估計，到 2023 年，全球醫院和療養院益生菌市場以金額為準6,900 萬美元。 BlueWeave 預測，在 2024 年至 2030 年的預測期內，醫院和療養院益生菌的全球市場規模將以 4.30% 的複合年成長率成長，到 2030 年將達到 9,110 萬美元。人們越來越認知到益生菌在促進腸道健康和免疫力方面的作用，特別是在老年人和慢性疾病患者等弱勢群體中，這推動了醫院和療養院益生菌的全球市場。胃腸道疾病的盛行率不斷上升，對非侵入性治療的需求不斷成長，以及在醫療機構中擴大採用益生菌來預防感染和支持康復，也推動了市場的成長。此外，益生菌配方的進步和醫療保健成本的上升進一步推動了醫院和療養院的需求。

機會－對個人化醫療的日益偏好

個人化醫療的不斷成長趨勢是全球醫院和療養院益生菌市場的關鍵成長要素。隨著人們對微生物組個體差異的認知不斷增強，醫療保健提供者正在轉向客製化益生菌治療來解決特定的健康狀況。這種方法可確保更好的患者治療效果，尤其是消化器官系統、免疫系統和心理健康問題。在微生物組研究和基因組分析進展的支持下，個人化益生菌配方正在刺激醫院和療養院的需求，並推動市場擴張。

地緣政治緊張局勢加劇對全球醫院和護理機構益生菌市場的影響

不斷升級的地緣政治緊張局勢正在影響全球醫院和療養院益生菌市場，導致供應鏈中斷、貿易限制和關稅增加，特別是可能影響原料的採購和分銷。這可能會導致製造和物流的成本增加、延誤和不確定性。此外，關鍵地區的政治不穩定可能會限制市場進入並影響產品的供應和定價。醫療保健預算也可能變得更加緊張，這可能會減少醫院和療養院對益生菌的需求。

腸道健康領域按應用引領市場

人們對消化器官系統健康的認知不斷提高，以及益生菌在維持健康腸道微生物組方面的益處，推動腸道健康領域在全球醫院和療養院益生菌市場中佔據最大佔有率。益生菌廣泛應用於醫院和療養院，以預防和治療常見的胃腸道疾病。腸道健康益生菌的需求源自於其改善消化和改善整體健康結果的功效。

競爭格局

全球醫院和療養院益生菌市場競爭非常激烈，許多公司都在爭奪更大的市場佔有率。市場主要企業包括 Bio-K Plus International、American Lifeline、Rising Pharmaceuticals、Becton Dickinson and Company、NutraScience Labs、Vitakem Nutraceuticals、Probium、Protexin、Nutraceutix、Nebraska Cultures、Mercola、Eva Nutra、UP4 Probiotics 等。這些公司正在利用各種策略，包括增加研發活動投資、併購、合資、聯盟、許可協議以及發布新產品和服務，以進一步佔領全球醫院和療養院益生菌市場。

本報告的詳細分析提供了有關全球醫院和療養院益生菌市場的成長潛力、未來趨勢和統計數據的資訊。它還重點關注推動市場總規模預測的因素。該報告致力於提供全球醫院和療養院益生菌市場的最新技術趨勢以及產業見解，幫助決策者做出策略決策。此外，我們也分析了市場的成長動力、挑戰和競爭力。

目錄

第1章 研究框架

第 2 章執行摘要

第3章 全球醫院和護理機構益生菌市場洞察

  • 產業價值鏈分析
  • DROC分析
    • 生長促進因子
      • 提高對益生菌的認知
      • 醫療費用增加
      • 慢性病流行
    • 抑制因素
      • 益生菌市場缺乏標準化
      • 與益生菌相關的監管挑戰
      • 益生菌產品高成本
    • 機會
      • 個性化醫療的成長趨勢
      • 擴大益生菌的應用範圍
      • 醫療保健需求日益成長的發展中國家
    • 任務
      • 確保益生菌菌株的品質和一致性
      • 與非專利藥的競爭
  • 科技進步/最新趨勢
  • 法律規範
  • 波特五力分析

第4章醫院和護理機構的全球益生菌市場：行銷策略

第5章醫院和護理機構的全球益生菌市場：價格分析

第6章醫院和護理機構的全球益生菌市場：區域分析

  • 全球醫院和護理機構益生菌市場區域分析，2023 年
  • 2024-2030年全球益生菌市場對醫院和護理機構的吸引力分析

第7章全球醫院和護理機構益生菌市場概述

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
      • 乳酸菌
      • 雙歧桿菌
      • 革蘭氏陽性球菌
      • 其他
    • 按用途
      • 腸道健康
      • 免疫
      • 健康
      • 其他
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第8章 北美醫院和護理機構益生菌市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 按用途
    • 按國家/地區
      • 美國
      • 加拿大

第9章歐洲醫院和護理機構益生菌市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 按用途
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲國家

第10章亞太地區醫院和護理機構益生菌市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 按用途
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲和紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區其他地區

第11章拉丁美洲醫院和護理機構的益生菌市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 按用途
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第12章中東和非洲醫院和護理機構的益生菌市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 按用途
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 其他中東/非洲

第13章競爭格局

  • 主要參與者及其產品列表
  • 2023 年全球醫院和護理機構益生菌市場佔有率分析
  • 透過管理參數進行競爭基準基準化分析
  • 重大策略發展（合併、收購、聯盟等）

第14章地緣政治緊張局勢加劇對全球醫院和療養院益生菌市場的影響

第15章 公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人員、主要競爭對手、聯絡方式、策略展望、SWOT分析）

  • Bio-K Plus International
  • American Lifeline
  • Rising Pharmaceuticals
  • Becton Dickinson and Company
  • NutraScience Labs
  • Vitakem Nutraceuticals
  • Probium
  • Protexin
  • Nutraceutix
  • Nebraska Cultures
  • Mercola
  • Eva Nutra
  • UP4 Probiotics
  • 其他主要企業

第16章 主要策略建議

第17章調查方法

簡介目錄
Product Code: BWC24802

Global Hospital and Nursing Home Probiotics Market Set to Surpass USD 91 Million by 2030

Global Hospital and Nursing Home Probiotics Market is thriving due to a rising awareness about gut health, increasing use of probiotics to prevent infections, growing elderly population, and an increasing demand for personalized healthcare.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Hospital and Nursing Home Probiotics Market size by value at USD 69.00 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Hospital and Nursing Home Probiotics Market size to expand at a CAGR of 4.30% reaching a value of USD 91.10 million by 2030. Global Hospital and Nursing Home Probiotics Market is driven by the growing awareness about probiotics' role in enhancing gut health and immunity, particularly in vulnerable populations such as the elderly and patients with chronic illnesses. The increasing prevalence of gastrointestinal disorders, rising demand for non-invasive treatments, and the growing adoption of probiotics for infection prevention and recovery support in healthcare settings also fuel market growth. Additionally, advancements in probiotic formulations and increased healthcare expenditures further boost demand in hospitals and nursing homes.

Opportunity - Growing Preference for Personalized Medicine

Rising trend of personalized medicine is a significant growth driver for Global Hospital and Nursing Home Probiotics Market. With increasing awareness of individual microbiome variations, healthcare providers are turning to tailored probiotic treatments to address specific health conditions. This approach ensures better patient outcomes, particularly for digestive, immune, and mental health issues. Personalized probiotic formulations, backed by advancements in microbiome research and genomic analysis, are fueling demand in hospitals and nursing homes, promoting market expansion.

Impact of Escalating Geopolitical Tensions on Global Hospital and Nursing Home Probiotics Market

Escalating geopolitical tensions could impact Global Hospital and Nursing Home Probiotics Market by causing supply chain disruptions, trade restrictions, and increased tariffs, particularly affecting raw material sourcing and distribution. It may lead to higher costs, delays, and uncertainty in manufacturing and logistics. Additionally, market access could be limited due to political instability in key regions, affecting product availability and pricing. Healthcare budgets may also be strained, potentially reducing demand for probiotics in hospital and nursing home settings.

Gut Health Segment Leads the Market by Application

The gut health segment holds the largest share of Global Hospital and Nursing Home Probiotics Market by application, due to the increasing awareness of digestive health and the benefits of probiotics in maintaining a healthy gut microbiome. Probiotics are widely used to prevent and treat gastrointestinal disorders, which are common in hospital and nursing home settings. The demand for gut health probiotics is driven by their effectiveness in improving digestion and overall health outcomes.

Competitive Landscape

Global Hospital and Nursing Home Probiotics Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Bio-K Plus International, American Lifeline, Rising Pharmaceuticals, Becton Dickinson and Company, NutraScience Labs, Vitakem Nutraceuticals, Probium, Protexin, Nutraceutix, Nebraska Cultures, Mercola, Eva Nutra, and UP4 Probiotics. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Global Hospital and Nursing Home Probiotics Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Hospital and Nursing Home Probiotics Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technological trends in Global Hospital and Nursing Home Probiotics Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Hospital and Nursing Home Probiotics Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Growing awareness of probiotics
      • 3.2.1.2. Increasing healthcare expenditure
      • 3.2.1.3. Rising prevalence of chronic diseases
    • 3.2.2. Restraints
      • 3.2.2.1. Lack of standardization in the probiotic market
      • 3.2.2.2. Regulatory challenges associated with probiotics
      • 3.2.2.3. High costs of probiotic products
    • 3.2.3. Opportunities
      • 3.2.3.1. Growing trend of personalized medicine
      • 3.2.3.2. Expanding applications of probiotics
      • 3.2.3.3. Developing countries with growing healthcare needs
    • 3.2.4. Challenges
      • 3.2.4.1. Ensuring the quality and consistency of probiotic strains
      • 3.2.4.2. Competition from generic products
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Hospital and Nursing Home Probiotics Market: Marketing Strategies

5. Global Hospital and Nursing Home Probiotics Market: Pricing Analysis

6. Global Hospital and Nursing Home Probiotics Market: Geography Analysis

  • 6.1. Global Hospital and Nursing Home Probiotics Market, Geographical Analysis, 2023
  • 6.2. Global Hospital and Nursing Home Probiotics, Market Attractiveness Analysis, 2024-2030

7. Global Hospital and Nursing Home Probiotics Market Overview

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share and Forecast
    • 7.2.1. By Product
      • 7.2.1.1. Lactobacillus
      • 7.2.1.2. Bifidobacterium
      • 7.2.1.3. Gram-positive Cocci
      • 7.2.1.4. Others
    • 7.2.2. By Application
      • 7.2.2.1. Gut Health
      • 7.2.2.2. Immunity
      • 7.2.2.3. Wellness
      • 7.2.2.4. Others
    • 7.2.3. By Region
      • 7.2.3.1. North America
      • 7.2.3.2. Europe
      • 7.2.3.3. Asia Pacific (APAC)
      • 7.2.3.4. Latin America (LATAM)
      • 7.2.3.5. Middle East and Africa (MEA)

8. North America Hospital and Nursing Home Probiotics Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Country
      • 8.2.3.1. United States
      • 8.2.3.1.1. By Product
      • 8.2.3.1.2. By Application
      • 8.2.3.2. Canada
      • 8.2.3.2.1. By Product
      • 8.2.3.2.2. By Application

9. Europe Hospital and Nursing Home Probiotics Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Country
      • 9.2.3.1. Germany
      • 9.2.3.1.1. By Product
      • 9.2.3.1.2. By Application
      • 9.2.3.2. United Kingdom
      • 9.2.3.2.1. By Product
      • 9.2.3.2.2. By Application
      • 9.2.3.3. Italy
      • 9.2.3.3.1. By Product
      • 9.2.3.3.2. By Application
      • 9.2.3.4. France
      • 9.2.3.4.1. By Product
      • 9.2.3.4.2. By Application
      • 9.2.3.5. Spain
      • 9.2.3.5.1. By Product
      • 9.2.3.5.2. By Application
      • 9.2.3.6. Belgium
      • 9.2.3.6.1. By Product
      • 9.2.3.6.2. By Application
      • 9.2.3.7. Russia
      • 9.2.3.7.1. By Product
      • 9.2.3.7.2. By Application
      • 9.2.3.8. The Netherlands
      • 9.2.3.8.1. By Product
      • 9.2.3.8.2. By Application
      • 9.2.3.9. Rest of Europe
      • 9.2.3.9.1. By Product
      • 9.2.3.9.2. By Application

10. Asia Pacific Hospital and Nursing Home Probiotics Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Country
      • 10.2.3.1. China
      • 10.2.3.1.1. By Product
      • 10.2.3.1.2. By Application
      • 10.2.3.2. India
      • 10.2.3.2.1. By Product
      • 10.2.3.2.2. By Application
      • 10.2.3.3. Japan
      • 10.2.3.3.1. By Product
      • 10.2.3.3.2. By Application
      • 10.2.3.4. South Korea
      • 10.2.3.4.1. By Product
      • 10.2.3.4.2. By Application
      • 10.2.3.5. Australia & New Zealand
      • 10.2.3.5.1. By Product
      • 10.2.3.5.2. By Application
      • 10.2.3.6. Indonesia
      • 10.2.3.6.1. By Product
      • 10.2.3.6.2. By Application
      • 10.2.3.7. Malaysia
      • 10.2.3.7.1. By Product
      • 10.2.3.7.2. By Application
      • 10.2.3.8. Singapore
      • 10.2.3.8.1. By Product
      • 10.2.3.8.2. By Application
      • 10.2.3.9. Vietnam
      • 10.2.3.9.1. By Product
      • 10.2.3.9.2. By Application
      • 10.2.3.10. Rest of APAC
      • 10.2.3.10.1. By Product
      • 10.2.3.10.2. By Application

11. Latin America Hospital and Nursing Home Probiotics Market

  • 11.1. Market Size & Forecast, 2019-2030
    • 11.1.1. By Value (USD Million)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Application
    • 11.2.3. By Country
      • 11.2.3.1. Brazil
      • 11.2.3.1.1. By Product
      • 11.2.3.1.2. By Application
      • 11.2.3.2. Mexico
      • 11.2.3.2.1. By Product
      • 11.2.3.2.2. By Application
      • 11.2.3.3. Argentina
      • 11.2.3.3.1. By Product
      • 11.2.3.3.2. By Application
      • 11.2.3.4. Peru
      • 11.2.3.4.1. By Product
      • 11.2.3.4.2. By Application
      • 11.2.3.5. Rest of LATAM
      • 11.2.3.5.1. By Product
      • 11.2.3.5.2. By Application

12. Middle East & Africa Hospital and Nursing Home Probiotics Market

  • 12.1. Market Size & Forecast, 2019-2030
    • 12.1.1. By Value (USD Million)
  • 12.2. Market Share & Forecast
    • 12.2.1. By Product
    • 12.2.2. By Application
    • 12.2.3. By Country
      • 12.2.3.1. Saudi Arabia
      • 12.2.3.1.1. By Product
      • 12.2.3.1.2. By Application
      • 12.2.3.2. UAE
      • 12.2.3.2.1. By Product
      • 12.2.3.2.2. By Application
      • 12.2.3.3. Qatar
      • 12.2.3.3.1. By Product
      • 12.2.3.3.2. By Application
      • 12.2.3.4. Kuwait
      • 12.2.3.4.1. By Product
      • 12.2.3.4.2. By Application
      • 12.2.3.5. South Africa
      • 12.2.3.5.1. By Product
      • 12.2.3.5.2. By Application
      • 12.2.3.6. Nigeria
      • 12.2.3.6.1. By Product
      • 12.2.3.6.2. By Application
      • 12.2.3.7. Algeria
      • 12.2.3.7.1. By Product
      • 12.2.3.7.2. By Application
      • 12.2.3.8. Rest of MEA
      • 12.2.3.8.1. By Product
      • 12.2.3.8.2. By Application

13. Competitive Landscape

  • 13.1. List of Key Players and Their Offerings
  • 13.2. Global Hospital and Nursing Home Probiotics Market Share Analysis, 2023
  • 13.3. Competitive Benchmarking, By Operating Parameters
  • 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Impact of Escalating Geopolitical Tensions on Global Hospital and Nursing Home Probiotics Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 15.1. Bio - K Plus International
  • 15.2. American Lifeline
  • 15.3. Rising Pharmaceuticals
  • 15.4. Becton Dickinson and Company
  • 15.5. NutraScience Labs
  • 15.6. Vitakem Nutraceuticals
  • 15.7. Probium
  • 15.8. Protexin
  • 15.9. Nutraceutix
  • 15.10. Nebraska Cultures
  • 15.11. Mercola
  • 15.12. Eva Nutra
  • 15.13. UP4 Probiotics
  • 15.14. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

  • 17.1. Qualitative Research
    • 17.1.1. Primary & Secondary Research
  • 17.2. Quantitative Research
  • 17.3. Market Breakdown & Data Triangulation
    • 17.3.1. Secondary Research
    • 17.3.2. Primary Research
  • 17.4. Breakdown of Primary Research Respondents, By Region
  • 17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable